Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BalansPlus
- Development stage
- Unknown
- Lead developer
- Allderma
- Administration
- Oral
01
Overview
BalansPlus is an oral dietary supplement developed by Allderma AB through its subsidiary Baltex Health & Beauty AB. It is formulated with Swedish pollen extract, red clover, and a vitamin B complex. The supplement is primarily marketed in the Nordic region to support hormonal balance and general well-being in women during menopause. As a nutraceutical product, it is regulated as a food supplement rather than a medicinal drug and does not have a defined pharmacological mechanism of action or specific biological target in the traditional therapeutic sense. It is approved for sale as a nutritional product rather than a therapeutic drug.
- Brand names
- BalansPlus
Beyond the preview
Go deeper on BalansPlus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BalansPlus.